Literature DB >> 17982432

The effect of white matter lesions on cognition in the elderly--small but detectable.

Giovanni B Frisoni1, Samantha Galluzzi, Leonardo Pantoni, Massimo Filippi.   

Abstract

The extent to which white matter changes affect brain function in elderly individuals is a matter for debate. Although there is a consensus that large confluent white matter lesions (WMLs) can be attributed to small-vessel disease and might denote anatomical damage to axons, the clinical effect of WMLs with regard to cognitive impairment is less certain. In this Review, we argue that WMLs are associated with greater detectable progressive cognitive deterioration than is normal aging, but other causes of progressive cognitive deterioration, such as Alzheimer's disease, are associated with greater cognitive decline than are WMLs. This view has important implications for the development of drugs for the treatment and prevention of cognitive impairment and dementia.

Entities:  

Mesh:

Year:  2007        PMID: 17982432     DOI: 10.1038/ncpneuro0638

Source DB:  PubMed          Journal:  Nat Clin Pract Neurol        ISSN: 1745-834X


  39 in total

Review 1.  Vascular disease and cognitive impairment.

Authors:  Christiane Reitz; José A Luchsinger; Richard Mayeux
Journal:  Expert Rev Neurother       Date:  2008-08       Impact factor: 4.618

Review 2.  The clinical use of structural MRI in Alzheimer disease.

Authors:  Giovanni B Frisoni; Nick C Fox; Clifford R Jack; Philip Scheltens; Paul M Thompson
Journal:  Nat Rev Neurol       Date:  2010-02       Impact factor: 42.937

Review 3.  Altered human brain anatomy in chronic smokers: a review of magnetic resonance imaging studies.

Authors:  Chao Wang; Xiaojun Xu; Wei Qian; Zhujing Shen; Minming Zhang
Journal:  Neurol Sci       Date:  2015-01-11       Impact factor: 3.307

4.  Pathways linking regional hyperintensities in the brain and slower gait.

Authors:  Niousha Bolandzadeh; Teresa Liu-Ambrose; Howard Aizenstein; Tamara Harris; Lenore Launer; Kristine Yaffe; Stephen B Kritchevsky; Anne Newman; Caterina Rosano
Journal:  Neuroimage       Date:  2014-05-17       Impact factor: 6.556

5.  Lower neurocognitive function in U-2 pilots: Relationship to white matter hyperintensities.

Authors:  Stephen A McGuire; David F Tate; Joe Wood; John H Sladky; Kent McDonald; Paul M Sherman; Elaine S Kawano; Laura M Rowland; Beenish Patel; Susan N Wright; Elliot Hong; Jennifer Rasmussen; Adam M Willis; Peter V Kochunov
Journal:  Neurology       Date:  2014-07-09       Impact factor: 9.910

6.  Brain atrophy in cerebral small vessel diseases: Extent, consequences, technical limitations and perspectives: The HARNESS initiative.

Authors:  François De Guio; Marco Duering; Franz Fazekas; Frank-Erik De Leeuw; Steven M Greenberg; Leonardo Pantoni; Agnès Aghetti; Eric E Smith; Joanna Wardlaw; Eric Jouvent
Journal:  J Cereb Blood Flow Metab       Date:  2019-11-20       Impact factor: 6.200

Review 7.  Current and future uses of neuroimaging for cognitively impaired patients.

Authors:  Gary W Small; Susan Y Bookheimer; Paul M Thompson; Greg M Cole; S-C Huang; Vladimir Kepe; Jorge R Barrio
Journal:  Lancet Neurol       Date:  2008-02       Impact factor: 44.182

8.  Multi-parametric neuroimaging evaluation of cerebrotendinous xanthomatosis and its correlation with neuropsychological presentations.

Authors:  Chiung-Chih Chang; Chun-Chung Lui; Jiun-Jie Wang; Shu-Hua Huang; Cheng-Hsien Lu; Ching Chen; Chih-Feng Chen; Min-Chien Tu; Chi-Wei Huang; Wen-Neng Chang
Journal:  BMC Neurol       Date:  2010-07-06       Impact factor: 2.474

9.  Tract-specific fractional anisotropy predicts cognitive outcome in a community sample of middle-aged participants with white matter lesions.

Authors:  Juan José Soriano-Raya; Júlia Miralbell; Elena López-Cancio; Núria Bargalló; Juan Francisco Arenillas; Maite Barrios; Cynthia Cáceres; Pere Toran; Maite Alzamora; Antoni Dávalos; Maria Mataró
Journal:  J Cereb Blood Flow Metab       Date:  2014-02-19       Impact factor: 6.200

10.  Regional white matter hyperintensities: aging, Alzheimer's disease risk, and cognitive function.

Authors:  Alex C Birdsill; Rebecca L Koscik; Erin M Jonaitis; Sterling C Johnson; Ozioma C Okonkwo; Bruce P Hermann; Asenath Larue; Mark A Sager; Barbara B Bendlin
Journal:  Neurobiol Aging       Date:  2013-10-10       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.